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 Table 1. Baseline Demographics of Patients with WPW Ablation
Variables Total Population Males Females p value
Age (years) 37.37 + 0.29 36.78 + 0.38 38.16 + 0.46 0.02
Length of stay (days) 1.82 + 0.04 1.91 + 0.07 1.7 + 0.05 0.02
Complete heart block (%) 1.08 1.37 0.71 0.13
Cardiac tamponade (%) 0.26 0.23 0.31 0.71
Pericardial complications (%) 0.9 0.68 1.22 0.17
Hemorrhage requiring transfusion (%) 0.12 0.15 - 0.66
Cerebrovascular accident (%) 0.22 0.32 - 0.27
Acute kidney injury (%) 0.55 0.67 0.9 0.37
Thromboembolism (%) 0.33 0.23 0.47 0.31
Pneumothorax (%) 0.04 - 0.10 0.25
Any cardiac complications (%) 2.3 2.27 2.35 0.89
Any complications 4.27 4.66 3.83 0.33
Hospital Volumes
    Tertile I 35.67 36.57 34.67  
    Tertile II 34.03 33.05 35.26  
    Tertile III 30.03 30.38 30.08
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The exact prevalence of Wolff-Parkinson White (WPW) syndrome in unknown 
but it is estimated to be between 0.068-0.17%. The short refractory period 
of the accessory pathway may result in conduction to the ventricles resulting 
in rapid ventricular response.  This could degenerate in ventricular fibrillation 
and cause sudden cardiac death with an estimated risk around 0.15% per 
patient-year. The era of catheter ablation for the treatment of arrhythmias 
began in 1981 when Dr. Scheinman performed first atrioventricular junction 
ablation in patient with refractory atrial fibrillation with rapid ventricular 
response.  Since then the art of direct current catheter ablation has advanced 
over to radiofrequency catheter ablation resulting in increasing number of 
patients being safely treated for arrhythmias. The radiofrequency catheter 
ablation for WPW syndrome was introduced in 1987 and since then has 
become the preferred treatment in patients with WPW with or without 
tachycardia. Aim of our study was to determine temporal trends in utilization 
of catheter ablation of WPW syndrome in the United States using a large 
national database.
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MATERIALS & METHODS
We analyzed data from the Healthcare Cost and Utilization Project of the 
Agency for Healthcare Research and Quality, Rockville, MD from the years 
1998–2011.  This registry represents up to 8 million hospital stays from 
1000 hospitals accounting for 20 % of all inpatient admissions to non-
federal hospitals in United States.  National estimates are produced using 
sampling weights provided by National Inpatient Sample (NIS). All patients 
≥18 years of age with a primary diagnosis of WPW syndrome (International 
Classification of Diseases, Ninth Edition, Clinical Modification [ICD-9-CM] 
code 426.7) were included in the study. Patients with supraventricular and 
ventricular arrhythmias were excluded from the analysis.  Patients who 
underwent catheter ablation were identified using ICD-9-CM procedure code 
37.34.  Temporal trends in catheter ablation were analyzed using chi2 test for 
trend.  Census data were used for population estimates in order to calculate 
time trends in utilization rates.  All calculations were carried out using the 
weighted estimates approximating nationwide population estimates.
RESULTS
Mean age in our study population was 37.3 ± 14.2 years.  A total of 
211,601 catheter ablations were performed from 1998 to 2011.  As seen 
in the figure 1, the utilization trends of catheter ablation have steadily 
decreased from 3.04-procedure/million populations in 1998 to 2.24-
procedure/million population in 2011 (p trend <0.001).  The overall rate 
of any complications was 4.3%, with cardiac complications in 2.3 %, 
pericardial complications 0.9%, and complete heart block in 1%, There 
was no vascular complications and  in-hospital mortality in our study. 
We also found that female sex and increase. The procedure perfprmed 
at the high volume hospitals (2nd and 3rd tertile) were associated with 
significant reduction in complications and length of stay when compared 
to those performed at the lowest volume centers.
CONCLUSION
Catheter ablation for WPW syndrome is a relatively safe procedure 
associated with low burden of morbidity and mortality. Low hospital 
volume is associated with increased length of stay and procedural 
complications.
 Table 2. Complications Based on Hospital Volumes




Tertile III p value
Complete heart block 0.6 0.18 0.3 0.08
Cardiac tamponade 0.26 0 0 0.004
Any cardiac complications 1.36 0.66 0.42 0.001
Any complications 2.23 1.14 0.9 0.002
 Table 3. Multimodel Regression Analysis to Determine 
Predictors of Length of Stay in Patients with WPW Ablation
Variables Oddds Ratio (95% CI) p value
Age 1.01 (1.01-1.02) <0.001
Female 0.81 (0.68-0.98) 0.03
Postoperative hemorrhage 0.66 (0.12-3.52) 0.62
Cerebrovascular accident 0.62 (0.05-0.14) 0.71
Acute kidney injury 4.72 (0.66-33.6) 0.09
Any complications 3.77 (0.66-21.4) 0.13
Hospital Volumes
    Tertile II 0.60 (0.48-0.74) <0.001 
    Tertile III 0.53 (0.43-0.67) <0.001
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